N-(4-(piperidin-4-yl)phenyl)acetamide | 668435-27-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: N-(4-(piperidin-4-yl)phenyl)acetamide
• 英文别名: N-(4-piperidin-4-ylphenyl)acetamide
• CAS: 668435-27-6
• 化学式: C₁₃H₁₈N₂O
• 分子量: 218.299
• InChiKey: LDISXGMBVDCVHC-UHFFFAOYSA-N

物化性质

• 沸点：
  418.2±45.0 °C(Predicted)
• 密度：
  1.092±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  16
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.46
• 拓扑面积：
  41.1
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  5-benzyl-6-chloro-1H-pyrimidine-2,4-dione 、 N-(4-(piperidin-4-yl)phenyl)acetamide 以 乙二醇甲醚 为溶剂， 反应 48.0h， 生成 No.46
  参考文献：
  名称：

  Discovery and optimization of novel, non-steroidal glucocorticoid receptor modulators

  摘要：

  A virtual screening approach comprising a 3-D similarity search based on known GR modulators was used to identify a novel series of non-steroidal glucocorticoid receptor (GR) antagonists. Optimization of the initial hit to provide potent compounds which exhibit good selectivity against other steroidal nuclear hormone receptors is described. (C) 2007 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2007.06.036

文献信息

• [EN] 20-HETE FORMATION INHIBITORS<br/>[FR] INHIBITEURS DE FORMATION DE 20-HETE
  申请人：UNIV OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION

  公开号：WO2020163689A1

  公开（公告）日：2020-08-13

  This disclosure provides novel heterocyclic compounds and methods for inhibiting the enzyme CYP4. Further disclosed methods include: a method of inhibiting the biosynthesis of 20-hydroxyeicosatetraenoic acid (20-HETE) in a subject in need thereof and a method of producing neuroprotection and decreased brain damage by preventing cerebral microvascular blood flow impairment and anti-oxidant mechanisms in a subject experiencing or having experienced an ischemic event.

  本公开提供了新颖的杂环化合物和抑制酶CYP4的方法。进一步公开的方法包括：一种抑制需要该物质的受试者体内20-羟基二十碳五烯酸（20-HETE）生物合成的方法，以及通过防止脑微血管血流受损和抗氧化机制来产生神经保护和减少脑损伤的方法，适用于正在经历或曾经经历缺血事件的受试者。
• DIAMINO HETEROCYCLIC CARBOXAMIDE COMPOUND
  申请人：Shimada Itsuro

  公开号：US20120040968A1

  公开（公告）日：2012-02-16

  Provided is a compound useful as an inhibitor against the kinase activity of EML4-ALK fusion protein. As a result of intensive and extensive studies on compounds having inhibitory activity against the kinase activity of EML4-ALK fusion protein, the present inventors found that the diamino heterocyclic carboxamide compounds of the present invention had inhibitory activity against the kinase activity of EML4-ALK fusion protein. By this finding, the present invention was completed. The compounds of the present invention can be used as a pharmaceutical composition for preventing and/or treating cancer, such as lung cancer, non-small cell lung cancer, and small cell lung cancer.

  提供的是一种化合物，可作为抑制EML4-ALK融合蛋白激酶活性的抑制剂。通过对具有抑制EML4-ALK融合蛋白激酶活性的化合物进行深入广泛的研究，本发明人发现本发明的二氨基杂环羧酰胺化合物对EML4-ALK融合蛋白激酶活性具有抑制作用。通过这一发现，完成了本发明。本发明的化合物可用作预防和/或治疗癌症，如肺癌、非小细胞肺癌和小细胞肺癌的药物组合物。
• 20-HETE FORMATION INHIBITORS
  申请人：UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION

  公开号：US20220144797A1

  公开（公告）日：2022-05-12

  This disclosure provides novel heterocyclic compounds and methods for inhibiting the enzyme CYP4. Further disclosed methods include: a method of inhibiting the biosynthesis of 20-hydroxyeicosatetraenoic acid (20-HETE) in a subject in need thereof and a method of producing neuroprotection and decreased brain damage by preventing cerebral microvascular blood flow impairment and anti-oxidant mechanisms in a subject experiencing or having experienced an ischemic event.
• US8969336B2
  申请人：——

  公开号：US8969336B2

  公开（公告）日：2015-03-03
• US9487491B2
  申请人：——

  公开号：US9487491B2

  公开（公告）日：2016-11-08